Sanofi’s dupilumab joins UK’s early access scheme

14th March 2017 Uncategorised 0

Patients with atopic dermatitis are to get early access to Sanofi’s dupilumab before its marketing authorisation in the UK, after the Medicines and Healthcare Products Regulatory Agency issued a positive scientific opinion for the drug through the country’s Early Access to Medicines Scheme.

More: Sanofi’s dupilumab joins UK’s early access scheme
Source: News